Literature DB >> 3796592

Growth factor requirements of oncogene-transformed NIH 3T3 and BALB/c 3T3 cells cultured in defined media.

X Zhan, M Goldfarb.   

Abstract

We report conditions for the efficient growth of NIH 3T3 and BALB/c 3T3 cells cultured in a defined medium supplemented with either platelet-derived growth factor (PDGF) or pituitary-derived fibroblast growth factor (FGF). The oncogenes v-mos, v-src, v-sis, and c-H-ras Val 12 can induce morphological transformation of these cells and can release them from the mitogen requirement for growth, while the oncogene v-fos cannot abrogate the PDGF-FGF requirement. The radically different behavior of normal and transformed NIH 3T3 cells in PDGF-FGF-free defined medium can form the basis of a sensitive new fibroblast transformation assay.

Mesh:

Substances:

Year:  1986        PMID: 3796592      PMCID: PMC367104          DOI: 10.1128/mcb.6.10.3541-3544.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  Purification of a fibroblast growth factor from bovine pituitary.

Authors:  D Gospodarowicz
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

2.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

3.  Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor.

Authors:  C D Scher; W J Pledger; P Martin; H Antoniades; C D Stiles
Journal:  J Cell Physiol       Date:  1978-12       Impact factor: 6.384

4.  Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process.

Authors:  W J Pledger; C D Stiles; H N Antoniades; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

5.  Dual control of cell growth by somatomedins and platelet-derived growth factor.

Authors:  C D Stiles; G T Capone; C D Scher; H N Antoniades; J J Van Wyk; W J Pledger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  Induction of cell division in medium lacking serum growth factor by SV40.

Authors:  H S Smith; C D Scher; G J Todaro
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

7.  Basis for the acquisition of malignant potential by mouse cells cultivated in vitro.

Authors:  S A Aaronson; G J Todaro
Journal:  Science       Date:  1968-11-29       Impact factor: 47.728

8.  Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses.

Authors:  E M Scolnick; A G Papageorge; T Y Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda.

Authors:  G F Vande Woude; M Oskarsson; L W Enquist; S Nomura; M Sullivan; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

10.  Human-tumor-derived cell lines contain common and different transforming genes.

Authors:  M Perucho; M Goldfarb; K Shimizu; C Lama; J Fogh; M Wigler
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

View more
  20 in total

1.  A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.

Authors:  Q X Li; J M Robbins; P J Welch; F Wong-Staal; J R Barber
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

2.  VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis.

Authors:  Jianying Dong; Jeremy Grunstein; Max Tejada; Frank Peale; Gretchen Frantz; Wei-Ching Liang; Wei Bai; Lanlan Yu; Joe Kowalski; Xiaohuan Liang; Germaine Fuh; Hans-Peter Gerber; Napoleone Ferrara
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

3.  A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.

Authors:  Alexander D Boiko; Sarah Porteous; Olga V Razorenova; Vadim I Krivokrysenko; Bryan R Williams; Andrei V Gudkov
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

4.  The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors.

Authors:  X Zhan; B Bates; X G Hu; M Goldfarb
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

5.  Growth factor-deprived BALB/c 3T3 murine fibroblasts can enter the S phase after induction of c-myc gene expression.

Authors:  F Cavalieri; M Goldfarb
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

6.  Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential.

Authors:  P Delli-Bovi; A M Curatola; K M Newman; Y Sato; D Moscatelli; R M Hewick; D B Rifkin; C Basilico
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

7.  Human recombinant insulin-like growth factor I. I. Development of a serum-free medium for clonal density assay of growth factors using BALB/c 3T3 mouse embryo fibroblasts.

Authors:  T L Riss; K P Karey; B D Burleigh; D Parker; D A Sirbasku
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

8.  Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor.

Authors:  M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression.

Authors:  S V Tavtigian; S D Zabludoff; B J Wold
Journal:  Mol Biol Cell       Date:  1994-03       Impact factor: 4.138

10.  K-252a and staurosporine selectively block autophosphorylation of neurotrophin receptors and neurotrophin-mediated responses.

Authors:  S H Nye; S P Squinto; D J Glass; T N Stitt; P Hantzopoulos; M J Macchi; N S Lindsay; N Y Ip; G D Yancopoulos
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.